HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
HCWB on Nasdaq
Shares outstanding
4,013,584
Price per share
$1.22
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
436,934
Total reported value
$424,098
% of total 13F portfolios
0%
Share change
+313,461
Value change
+$304,237
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Wong Hing C 23% $5,044,206 501,911 Hing C. Wong, Ph.D. 15 May 2025
ARMISTICE CAPITAL, LLC 10% $489,168 400,957 Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 14 institutional investors reported holding 436,934 shares of HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB). This represents 11% of the company’s total 4,013,584 outstanding shares.

Top 15 Institutional Shareholders

The largest institutional shareholders of HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 7.5% 300,180 0.01% $291,355
DRW Securities, LLC 0.88% 35,281 -58% 0% $34,243
CITADEL ADVISORS LLC 0.55% 22,158 0% $21,507
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.5% 20,071 0% $19,481
VANGUARD GROUP INC 0.38% 15,426 0% 0% $14,979
GEODE CAPITAL MANAGEMENT, LLC 0.35% 14,037 +28% 0% $13,625
J.W. COLE ADVISORS, INC. 0.31% 12,500 0% $12,133
Golden State Wealth Management, LLC 0.25% 10,000 0% 0% $9,706
Tower Research Capital LLC (TRC) 0.11% 4,504 +188% 0% $4,372
UBS Group AG 0.04% 1,739 0% $1,689
WELLS FARGO & COMPANY/MN 0.02% 1,000 -41% 0% $971
OSAIC HOLDINGS, INC. 0% 26 0% 0% $25
BANK OF AMERICA CORP /DE/ 0% 11 +10% 0% $11
CITIGROUP INC 0% 1 -100% 0% $1
SBI Securities Co., Ltd. 0% 0 -100% $0

Institutional Holders of HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 436,934 $424,098 +$304,237 $0.97 14
2025 Q3 123,473 $456,855 +$374,514 $3.70 10
2025 Q2 21,568 $85,518 +$85,518 $3.97 8